🇺🇸 FDA
Company

BICYCLE

BICYCLE THERAPEUTICS

BCYC pharma USA

Quick answer

BICYCLE is a pharma company (BCYC) headquartered in CAMBRIDGE, X0, USA with 2 tracked pipeline programs.

Pipeline (2)

project

BT1718

Advanced Solid Tumours

Phase 2 · small_molecule · completed

1 trials project

buprenorphine/naloxone

Opioid Use Disorder

Approved · small_molecule · terminated

1 trials

Drugs (7)

drug

cimetidine

CIMETIDINE

 drug

cimetidine hydrochloride

TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

 drug

fingolimod lauryl sulfate

TASCENSO ODT

 drug

piroxicam

PIROXICAM

 drug

quinidine gluconate

QUINIDINE GLUCONATE

 drug

quinidine sulfate

QUINIDINE SULFATE

 drug

reserpine

RESERPINE

Patents (8)

patent

US 12378288

Multimeric bicyclic peptide ligands

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12377155

Bicyclic peptide ligands specific for PSMA

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350343

Bicyclic peptide ligands specific for MT1-MMP

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318454

Bicyclic peptide ligands specific for MT1-MMP

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12150998

Bicyclic peptide ligands specific for P-selectin

Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12049520

Bicyclic peptide ligands specific for CD137

Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11970553

Heterotandem bicyclic peptide complex

Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11970555

Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)